Ropinirole

Common brands: Neurontin, Gralise, Gaba 300-Ezs, Gabapentin, Gabarone

Top reporter: Accord Healthcare Inc.

Nonergot Dopamine Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Proton Pump Inhibitor [EPC]Loop Diuretic [EPC]
14,931
Total Reports
5,822
Serious Reports
1,419
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.50%)

Patient Demographics

Male
5,240
Female
8,494

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ropinirole.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 1,176
6.8%
2 FALL 1,025
5.9%
3 FATIGUE 934
5.4%
4 NAUSEA 874
5.1%
5 DIZZINESS 734
4.3%
6 HALLUCINATION 732
4.2%
7 PAIN 641
3.7%
8 DEATH 638
3.7%
9 DIARRHOEA 614
3.6%
10 DYSPNOEA 597
3.5%
11 ASTHENIA 578
3.4%
12 OFF LABEL USE 559
3.2%
13 INSOMNIA 538
3.1%
14 HEADACHE 532
3.1%
15 GAIT DISTURBANCE 521
3.0%
16 SOMNOLENCE 520
3.0%
17 DYSKINESIA 505
2.9%
18 CONDITION AGGRAVATED 493
2.9%
19 TREMOR 487
2.8%
20 MALAISE 474
2.7%
21 VOMITING 440
2.6%
22 CHRONIC KIDNEY DISEASE 428
2.5%
23 PNEUMONIA 426
2.5%
24 WEIGHT DECREASED 415
2.4%
25 CONFUSIONAL STATE 402
2.3%
26 ANXIETY 400
2.3%
27 PARKINSON^S DISEASE 392
2.3%
28 URINARY TRACT INFECTION 392
2.3%
29 DEPRESSION 388
2.3%
30 ARTHRALGIA 384
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.